Ledger.Open graph →
SEC Form D · filed November 29, 2018

Aimmune Therapeutics, Inc

Offering
$98.0M
Sold
$98.0M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
BRISBANE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Eric H. Bjerkholt · Brisbane, CAExecMark D. Mcdade · South San Francisco, CADirectorPatrick G. Enright · Menlo Park, CADirectorMark T. Iwicki · Brisbane, CADirectorBrett K. Haumann · Brisbane, CADirectorDaniel C. Adelman · Brisbane, CAExecMary M. Rozenman · Brisbane, CAExecSusan E. Barrowcliffe · Brisbane, CAExecDouglas T. Sheehy · Brisbane, CAExecStacey D. Seltzer · New York, NYDirectorGregory E. Behar · Brisbane, CADirectorJayson D. Dallas · Brisbane, CAExec · DirectorKathryn E. Falberg · Broomfield, CODirectorEric H. Bjerkholt · South San Francisco, CAExecMark D. Mcdade · South San Francisco, CADirectorPatrick G. Enright · Plymouth, MIDirectorBrett K. Haumann · Brisbane, CADirectorDaniel C. Adelman · Brisbane, CAExecMary M. Rozenman · Brisbane, CAExecSusan E. Barrowcliffe · Brisbane, CAExecDouglas T. Sheehy · Brisbane, CAExecStacey D. Seltzer · New York, NYDirectorGregory E. Behar · Brisbane, CADirectorJayson D. Dallas · Brisbane, CAExec · DirectorKathryn E. Falberg · Brisbane, CADirectorMark T. Iwicki · Brisbane, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗